{"nct_id":"NCT04671251","title":"Phase 1b Study of AEVI-007 in Subjects With Relapsed or Refractory Multiple Myeloma","status":"COMPLETED","status_verified_date":"2024-02","start_date":"2020-12-15","start_date_type":"ACTUAL","primary_completion_date":"2022-03-30","primary_completion_date_type":"ACTUAL","completion_date":"2022-03-30","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["AVTX"]}